1. Home
  2. INM vs FE Comparison

INM vs FE Comparison

Compare INM & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • FE
  • Stock Information
  • Founded
  • INM 1981
  • FE 1996
  • Country
  • INM Canada
  • FE United States
  • Employees
  • INM N/A
  • FE N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • FE Electric Utilities: Central
  • Sector
  • INM Health Care
  • FE Utilities
  • Exchange
  • INM Nasdaq
  • FE Nasdaq
  • Market Cap
  • INM 4.3M
  • FE 23.9B
  • IPO Year
  • INM N/A
  • FE N/A
  • Fundamental
  • Price
  • INM $2.32
  • FE $43.08
  • Analyst Decision
  • INM
  • FE Buy
  • Analyst Count
  • INM 0
  • FE 16
  • Target Price
  • INM N/A
  • FE $46.14
  • AVG Volume (30 Days)
  • INM 44.9K
  • FE 3.2M
  • Earning Date
  • INM 11-13-2025
  • FE 10-28-2025
  • Dividend Yield
  • INM N/A
  • FE 4.13%
  • EPS Growth
  • INM N/A
  • FE 49.18
  • EPS
  • INM N/A
  • FE 2.27
  • Revenue
  • INM $4,920,990.00
  • FE $13,864,000,000.00
  • Revenue This Year
  • INM N/A
  • FE $8.73
  • Revenue Next Year
  • INM N/A
  • FE $3.41
  • P/E Ratio
  • INM N/A
  • FE $19.01
  • Revenue Growth
  • INM N/A
  • FE 6.52
  • 52 Week Low
  • INM $1.72
  • FE $37.58
  • 52 Week High
  • INM $8.27
  • FE $44.78
  • Technical
  • Relative Strength Index (RSI)
  • INM 54.40
  • FE 46.98
  • Support Level
  • INM $2.11
  • FE $42.87
  • Resistance Level
  • INM $2.28
  • FE $43.93
  • Average True Range (ATR)
  • INM 0.10
  • FE 0.48
  • MACD
  • INM 0.03
  • FE -0.09
  • Stochastic Oscillator
  • INM 87.35
  • FE 19.81

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About FE FirstEnergy Corp.

FirstEnergy is an investor-owned holding company with 10 regulated distribution utilities across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.

Share on Social Networks: